National Health Service (NHS) Secretary Amir Ashraf Khawaja while briefing the Public Accounts Committee on Thursday said that the Pakistan government has no plan to buy vaccines anytime soon

So far, the Pfizer-BioNTtech and Moderna vaccines, made through a novel platform technology never used in humans before, are proven to have maximum efficacy

The government, in this phase, will vaccinate people over 60 and individuals over 45 with comorbidities to rein in the rising number of more infectious virus strains leading to a spurt in COVID-19 cases in some states

Biological E has tied up with vaccine maker Johnson & Johnson and Baylor College of Medicine in Houston. And, it plans to start the Phase 3 trial of the candidate licensed from Baylor College next week

Russia has already approved two COVID-19 vaccines, Sputnik V and EpiVacCorona, which were also granted approval before seeing any late-stage trial results

As part of the review process, Dr Reddy's will present the safety profile of the phase 2 study, and interim data of the phase 3 study, which is expected to complete by 21st February 2021.

Saying that vaccination is necessary to fight the pandemic, Guleria urged people to not be afraid of the vaccine as it is totally safe.

Having reported the highest number of coronavirus infections after the United States, and with the world's biggest vaccine-making capacity, India says it has been the fastest to reach many inoculation milestones

With no relief in sight from incessant rise in petrol and diesel prices, people turned to Twitter to vent their frustrations on the matter; The central government is set to notify the rules under new labour codes, which will have an impact on employees' cost to company (CTC) as well as employers' wage bills; Vaccination drive against COVID-19 and improving economic indicators have enthused employers to recruit. Watch this and more on News Blast.Also Read: Amazon to manufacture Fire TV Stick in India from this year

Revival in job market: January sees 50% rise in vacancies over December Vaccination drive against COVID-19 and improving economic indicators has enthused employers to recruit. This was evident in a survey which showed job openings increased almost 50 per cent in January as compared to December. Vacancies in January rose to 265,000 from 180,000 in December, according to Xpheno's Active Job Outlook survey. COVID-19 vaccine: Russia's Sputnik V may be approved by India in next few weeks Ind...

Serum Institute has applied for registration with Health Canada with the help of Toronto-based Verity Pharmaceuticals, Adar Poonawalla said

Total 35 persons have been hospitalised after being administered a vaccine so far, which account for 0.0004 per cent of the total vaccinations

COVID-19 vaccine: The AstraZeneca-Oxford product is a viral vectored vaccine called ChAdOx1-S [recombinant], which is being produced at several manufacturing sites, as well as in the Republic of Korea and India

Earlier, Dr Reddy's had said it expects to roll out Sputnik V vaccine in India in March via Emergency Use Authorisation (EUA) after the completion of Phase 3 trials.

In India, we are fortunate that supply of vaccines is not a rate-limiting step, but to meet the timelines set by the government, we will have to immunise somewhere between 4 and 5 times more people each day than we are doing today, says Gagandeep Kang of Christian Medical College in Vellore

Just the two shots have been used in what India calls the world's biggest immunisation programme to cover 300 million people by August, starting with healthcare and other workers to reach the elderly and those with existing conditions by March

Another candidate, developed by CanSino Biologics Inc(CanSinoBIO), has also completed clinical trials in the South Asian nation of 220 million people

External Affairs Minister S Jaishankar said some poor countries are being supplied the vaccine on a grant basis, while some nations wanted it on par with the price that the Indian government pays to the vaccine makers

India boasts one of the biggest pharmaceutical industries globally and several countries have already approached it for procuring COVID-19 vaccines

The British researchers behind the trial said data on vaccinating people with the two different types of coronavirus vaccines could help understanding of whether shots can be rolled out with greater flexibility around the world